2006
DOI: 10.1038/sj.onc.1209606
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondria in hematopoiesis and hematological diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
57
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(58 citation statements)
references
References 166 publications
(154 reference statements)
0
57
1
Order By: Relevance
“…lymphoma predictor set) is normally specifically expressed in erythroid cells. Because defective ALAS2 has been linked to sideroblastic anemia and diminished heme production, ALAS2 function can enhance cellular survival, as excess iron promotes reactive oxygen species (38). Therefore, increased ALAS2 may function to decrease reactive oxygen species and promote mitochondrial stability.…”
Section: Discussionmentioning
confidence: 99%
“…lymphoma predictor set) is normally specifically expressed in erythroid cells. Because defective ALAS2 has been linked to sideroblastic anemia and diminished heme production, ALAS2 function can enhance cellular survival, as excess iron promotes reactive oxygen species (38). Therefore, increased ALAS2 may function to decrease reactive oxygen species and promote mitochondrial stability.…”
Section: Discussionmentioning
confidence: 99%
“…Qualitative aberrations of mtDNA, such as mutations, have been found in solid tumours, such as colon, stomach, liver, kidney, bladder, prostate, skin and lung cancer (Copeland et al 2002;Penta et al 2001), and in haematological malignancies, such as leukaemia and lymphoma (Fontenay et al 2006). Quantitative aberrations of mtDNA have been observed in various sample types from patients with cancers (Mambo et al 2005).…”
Section: Introductionmentioning
confidence: 99%
“…6 The metabolic status of HSC and HPC becomes crucial during clinical HSPC transplantation since the efficiency of donor-derived HSC/HPC to engraft, survive, home, proliferate and differentiate into multiple lineages in a chemotherapy-induced aplastic patient is markedly influenced by their hypoxic niche, demanding a significant metabolic adaptation to survive and promote rapid and stable hematopoietic reconstitution in chemotherapyinduced aplastic microenvironments. 7,8 As in other tissues, mitochondria play key roles in HSC/HPC and have recently come under increased scrutiny because compelling evidence has revealed their role in numerous cellular processes, beyond ATP production and apoptosis regulation, and they have recently even been suggested to act as cell-fate or lineage determinants. [9][10][11] In fact, deregulation of mitochondrial function plays a pathophysio- October 11, 2012.…”
Section: Introductionmentioning
confidence: 99%
“…logical role in a range of hematologic diseases, such as inherited dyserythropoiesis, sideroblastic anemias and low-grade myelodysplastic symdromes. 8,12 In addition, transcriptome, epigenetic and proteomic studies in stem cell systems have indicated that specific metabolic/mitochondrial properties are essential for regulating the balance between self-renewal and differentiation. 13,14 Although recent work has begun to shed light on the mitochondrial response during murine stem cell differentiation, 7,10,15,16 how and to what extent the mitochondrial mass/function contributes to human hematopoietic stem and progenitor function remains poorly understood.…”
Section: Introductionmentioning
confidence: 99%